Severo Ochoa Programme 2018-2022 Health NEWS

Monday, 30 May 2022

Severo Ochoa Workshop on the present and future of Nanomedicine

The event, which was organised by group leader Prof. Laura Lechuga and counted on the participations of many members of the ICN2 community, aimed at bringing together researchers in the field on nanomedicine, clinicians from relevant hospitals, and healthcare industry experts to share results and views both on recent advances in the field and on effective procedures to transfer new technologies into clinical practice.

Tuesday, 15 March 2022

INBRAIN Neuroelectronics signs an agreement to develop neurotechnology patented by six public research institutions

INBRAIN Neuroelectronics is a technology company developing graphene-based applications for neurological diseases founded by researchers from IMB-CNM-CSIC, ICN2 and ICREA who lead some of the research areas of the Graphene Flagship. The agreement paves the way for further development and industrialization of patented technology from CSIC, ICN2, ICREA, CIBERBBN, UAB and IDIBAPS.

Wednesday, 02 March 2022

A novel and clinically validated optical biosensor enables rapid and quantitative serological testing of COVID-19

An innovative nano-biosensor for fast, quantitative and accurate COVID-19 serology, which achieves the high reliability of specialised laboratory analysis with the short times and simplicity of rapid self-tests, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the ICN2 NanoBiosensors and Bioanalytical Applications Group. This work has been developed in collaboration with the Vall d'Hebron University Hospital and Research Institute (VHIR, Barcelona) and the Hospital Clínic of Barcelona–IDIBAPS –which provided the clinical samples and the validation— and the Emerging Virus Unit of Aix-Marseille University (France).

Wednesday, 09 February 2022

GLEBioassay project receives funding from EuroNanoMed

A project aiming at the nano-monitoring of cancer immunotherapy efficiency through a graphene electrophoretic bioassay platform, GLEBioassay, is one of the ten selected in the 12th Joint Trasnational Call for funding of the EuroNanoMed platform. The consortium will be led by Prof. Arben Merkoçi.

Thursday, 13 January 2022

State of the art and prospects in AttoSens, techniques for detecting ultra-low concentrations of analytes

A paper in “Chemical Society Review” discusses the progress over the last ten years in the development of biological and chemical sensing platforms for the detection of target analytes at ultra-low abundance level (attomolar). This work was coordinated by ICN2 group leader ICREA Prof. Arben Merkoçi and Prof. V.V.R. Sai, from the Indian Institute of Technology Madras (IITM).

Wednesday, 22 December 2021

New graphene-based neural probes improve detection of epileptic brain signals

A study published in Nature Nanotechnology shows that flexible brain probes made of graphene micro-transistors can be used to record pathological brain signals associated with epilepsy with excellent fidelity and high spatial resolution. This research was led by the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) and the University College London Queen Square Institute of Neurology (UK).

Wednesday, 24 November 2021

Researchers find a substance that facilitates natural cell suppression in aggressive brain cancer

A research team coordinated by Dr. Víctor J. Yuste of the Universitat Autònoma de Barcelona (UAB) demonstrated that the administration of a substance called “gossypol” to cells of glioblastoma, an incurable type of brain cancer, facilitates their death through the natural apoptosis mechanism. This study, in which took part members of the ICN2 Nanostructured Functional Materials Group, opens up a new avenue in the search for a treatment for glioblastoma.

Wednesday, 01 September 2021

Electrochromic materials for new point-of-care and wearable biosensors: a review

A scientific paper recently published in “Materials Today” highlights the potentialities offered by electrochromic materials for the development of portable and easy-to-use bio-sensing platforms. This work, coordinated by ICREA Prof. Arben Merkoçi, provides a comprehensive description and discussion about these materials, their properties, state-of-the art applications as biosensors and new opportunities and challenges in this field.

Monday, 28 June 2021

XVIII Burdinola Research Award Ceremony

Prof. Laura Lechuga, leader of the ICN2 Nanobiosensors and Bioanalytical Applications Group, received today the "XVIII Burdinola Research Award" in recognition of her career path and important work in the field of nanosensors for medical applications.

Thursday, 10 June 2021

Novel biosensing platform for point-of-care analysis of complex samples without pretreatment

A paper published in “Analytical Chemistry” describes an enhanced biosensing platform based on lateral-flow-assay (LFA) for point-of-care analysis. Cheap, easy to use and portable as LFA, this paper-based electrophoretic bioassay (PEB) allows performing tests on viscous samples, as whole blood, without the need for pretreatment steps. This research was developed by members of the ICN2 Nanobioelectronics and Biosensors Group.